AstraZeneca mulls additional trial to further investigate COVID vaccine efficacy: report
Preliminary results found AstraZeneca and Oxford University's vaccine appeared to be 62% effective when two full doses were given to...
Full Article
AstraZeneca mulls additional trial to further investigate COVID vaccine efficacy: report
Upworthy
0 shares
1 views
You might like
Related news coverage
AstraZeneca to launch a new global trial for its COVID-19 vaccine
Invezz
In a statement on Thursday, CEO Pascal Soriot of AstraZeneca plc (LON: AZN) expressed plans of launching a new global trial that..
-
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
-
AstraZeneca Likely To Run New Global Trial Of COVID-19 Vaccine
RTTNews
-
FTSE 100 Slides As Brexit Talks Drag On
RTTNews
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
Advertisement
More coverage
Asian Markets Mostly Lower
RTTNews
Asian stock markets are mostly lower on Friday in the absence of fresh cues from Wall Street, which was closed overnight for a..
-
India to consider clinical trials data of two full doses of AstraZeneca vaccine
IndiaTimes
-
AstraZeneca likely to run 'additional' COVID-19 vaccine trial as tricky questions emerge
SBS
-
AstraZeneca likely to run new global trial on COVID-19 vaccine - report
Jerusalem Post
-
AstraZeneca CEO says new global trial on COVID-19 vaccine likely
CBC.ca